1Wang M,Zhou Y,Zhang L,et al.Use of bortezomib in B-cell non-Hodgkin's lymphoma.Expert Rev Anticancer Ther,2006,6(7):983-991.
2Orlowski RZ,Voorhees PM,Garcia RA,et al.Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies.Blood,2005,105 (8):3058-3065.
4Adams J,Palombella VJ,Sausville EA,et al.Proteasome inhibitors:a novel class of potent and effective antitumor agents.Cancer Research,59(11):2615-2622.
5Leonard JP,Furman RR,Coleman M.Proteasome inhibition with bortezomib:a new therapeutic strategy for non-Hodgkin's lymphoma.Int J Cancer,2006,119(5):971-979.
6Goy A,Younes A,McLaughlin P,et al.Phase Ⅱ study of proteasome inhibitor bortezomib in relapsed or refractory B-cell nonHodgkin's lymphoma.J Clin Oncol,2005,23(4):667-668.
7Mitsiades N,Mitsiades CS,Richardson PG,et al.The porteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents:therapeutic applications.Blood.101 (6):2377-2380.
5Schiffelers RM,Storm G.Liposomal nanomedicines as anticancer therapeutics:beyond targeting tumor cells[J].International Journal of Pharmaceutics,2008,364(2):258-264.
6Ferrandina G,Corrado G,Licameli A,et al.Pegylated liposomal doxorubicin in the management of ovarian cancer[J].Ther Clin Risk Manag,2010,6:463-483.
7Yang T,Choi MK,Cui FD,et al.Antitumor effect of paclitaxel-loaded PEGylated immunoliposomes against human breast cancer cells[J].Pharmaceutical Research,2007,24(12):2401-2411.
8Feng B,Tomizawa K,Michiue H,et al.Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His[J].Biomaterials,2009,30(9):1746-1755.
9Feng B,Tomizawa K,Michiue H,et al.Development of a bifunctional immunoliposome system for combined drug delivery and imaging in vivo[J].Biomaterials,2010,31(14):4139-4145.
10Kitamura N,Shigematsu N,Nakahara T,et al.Biodistribution of immunoliposome labeled with Tc-99m in tumor xenografted mice[J].The Japanese Society of Nuclear Medicine,2009,23(2):149-153.
